{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:37:03Z","timestamp":1784169423138,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.imbio.2022.152236","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T20:53:55Z","timestamp":1654635235000},"page":"152236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Deciphering the balance of IL-6\/IL-10 cytokines in severe to critical COVID-19 patients"],"prefix":"10.1016","volume":"227","author":[{"given":"Mouna Ben","family":"Azaiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awatef Ben","family":"Jemaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Sellami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihebeddine","family":"Romdhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridha","family":"Ouslati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedi","family":"Gharsallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezzedine","family":"Ghazouani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Ferjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2022.152236_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108293","article-title":"Risk factors for mortality among COVID-19 patients","volume":"166","author":"Albitar","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.imbio.2022.152236_b0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/JLB.4COVA1020-703R","article-title":"Cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death","volume":"111","author":"Belaid","year":"2022","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.imbio.2022.152236_b0015","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2022.152236_b0020","doi-asserted-by":"crossref","unstructured":"Chen, J., Liu,. Y, Qin, J., Ruan, C., Zeng,. X, Xu, A., Yang, R., Li, J., Cai, H., Zhang, Z., 2021. Hypertension as an independent risk factor for severity and mortality in patients with COVID-19: a retrospective study. Postgrad. Med. J. Oct 5:postgradmedj-140674. doi: 10.1136\/postgradmedj-2021-140674.","DOI":"10.1136\/postgradmedj-2021-140674"},{"issue":"4","key":"10.1016\/j.imbio.2022.152236_b0025","doi-asserted-by":"crossref","first-page":"2003006","DOI":"10.1183\/13993003.03006-2020","article-title":"Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome","volume":"56","author":"Chen","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.imbio.2022.152236_b0030","doi-asserted-by":"crossref","unstructured":"Chen, R., Lan, Z., Ye, J., Liu, Y., Zhang, P., 2021. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Front. Immunol. 28(12),589095. doi: 10.3389\/fimmu.2021.589095. PMID: 33995341; PMCID: PMC8115911.","DOI":"10.3389\/fimmu.2021.589095"},{"issue":"1","key":"10.1016\/j.imbio.2022.152236_b0035","first-page":"147","article-title":"Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology","volume":"285","author":"Cicchese","year":"2018","journal-title":"Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2022.152236_b0040","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/art.39295","article-title":"Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome","volume":"67","author":"Cifaldi","year":"2015","journal-title":"Arthritis. Rheumatol."},{"key":"10.1016\/j.imbio.2022.152236_b0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/microorganisms8050695","article-title":"Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo Covid19 registry (SMACORE)","volume":"8","author":"Colaneri","year":"2020","journal-title":"Microorganisms"},{"issue":"11","key":"10.1016\/j.imbio.2022.152236_b0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with Coronavirus Disease 2019 (COVID-19)","volume":"1","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2022.152236_b0055","doi-asserted-by":"crossref","unstructured":"Fajgenbaum, D.C, C.H., 2020. Cytokine Storm. N. Engl. J. Med. 383(23), 2255-227. PubMed| Google Scholar.","DOI":"10.1056\/NEJMra2026131"},{"key":"10.1016\/j.imbio.2022.152236_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.624483","article-title":"T-helper cell subset response is a determining factor in COVID-19 progression","volume":"11","author":"Gil-Etayo","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"10.1016\/j.imbio.2022.152236_b0065","doi-asserted-by":"crossref","first-page":"e0244628","DOI":"10.1371\/journal.pone.0244628","article-title":"Interleukine-6 in critically ill COVID-19 patients: a retrospective analysis","volume":"15","author":"Gorham","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.imbio.2022.152236_b0070","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID- 19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microbes. Infect."},{"issue":"7","key":"10.1016\/j.imbio.2022.152236_b0075","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4049\/jimmunol.2001327","article-title":"The inflammatory factors associated with disease severity to predict COVID-19 progression","volume":"206","author":"Huang","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2022.152236_b0080","doi-asserted-by":"crossref","unstructured":"Jesenak, M., Brndiarova, M., Urbancikova, I et al., 2020. Immune parameters and COVID-19 infection\u2014associations with clinical severity and disease prognosis. Front. Infect Microbiol. 10,1\u201310. Iran J. Immunol.. Dec;18(4):331-337. doi: 10.22034\/IJI.2021.89905.1978.","DOI":"10.3389\/fcimb.2020.00364"},{"key":"10.1016\/j.imbio.2022.152236_b0085","doi-asserted-by":"crossref","unstructured":"Kimmig, L.M., Wu, D., Gold, M., Pettit, N.N. Pitrak, D., Mutlu, E.A., Mutlu. G.M., 2020. IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections. Front. Med. (Lausanne).28(7), 583897.","DOI":"10.3389\/fmed.2020.583897"},{"key":"10.1016\/j.imbio.2022.152236_b0090","doi-asserted-by":"crossref","unstructured":"Kumar, V., 2019.Immunometabolism:Another Road to Sepsis and Its Therapeutic Targeting. Inflammation. 42(3),765-788.","DOI":"10.1007\/s10753-018-0939-8"},{"issue":"3","key":"10.1016\/j.imbio.2022.152236_b0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s10753-014-0063-3","article-title":"Alterations of T helper lymphocyte subpopulations in sepsis, severe sepsis, and septic shock: a prospective observational study","volume":"38","author":"Li","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.imbio.2022.152236_b0100","doi-asserted-by":"crossref","unstructured":"Li, C.H., Chiou, H.C., Lin, M.H., Kuo, C.H., Kuo, Y.H., 2021. Immunological map in COVID-19. J. Microbiol. Infect. 54(4),547-556. doi: 10.1016\/j.jmii.2021.04.006. Epub 2021 May 12. PMID: 34023234; PMCID: PMC8114810.","DOI":"10.1016\/j.jmii.2021.04.006"},{"key":"10.1016\/j.imbio.2022.152236_b0105","doi-asserted-by":"crossref","unstructured":"Liu, J., Li, S., Liu, J., 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBio. Medicine 55. Epub ahead of print.","DOI":"10.1016\/j.ebiom.2020.102763"},{"key":"10.1016\/j.imbio.2022.152236_b0110","doi-asserted-by":"crossref","unstructured":"Liu, K., Yang, T., Peng, X.M., Ye, X.L., Liu, W., 2021 .A systematic meta-analysis of immune signatures in patients with COVID-19. Rev. Med. Virol. 31(4),2195. doi: 10.1002\/rmv.2195. Epub 2020 Nov 20. PMID: 34260780; PMCID: PMC7744845.","DOI":"10.1002\/rmv.2195"},{"key":"10.1016\/j.imbio.2022.152236_b0115","first-page":"193","article-title":"Coronaviruses and SARS-CoV-2: a brief overview","volume":"13","author":"Ludwig","year":"2020","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.imbio.2022.152236_b0120","first-page":"1","article-title":"Circulating levels of IL-2, IL-4, TNF-\u03b1, IFN-\u03b3, and C-reactive protein are not associated with severity of COVID-19 symptoms","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152236_b0125","doi-asserted-by":"crossref","first-page":"13995","DOI":"10.1038\/s41598-018-32275-8","article-title":"The clinical importance of a cytokine network in the acute phase of sepsis","volume":"8","author":"Matsumoto","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.imbio.2022.152236_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.imbio.2022.152236_b0135","article-title":"Pro- and anti- inflammatory responses in severe COVID-19-induced acute respiratory distress syndrome-an observational pilot study","volume":"6","author":"Notz","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2022.152236_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin- 6 is a biomarker for the development of fatal severe acute respiratory syndrome Coronavirus 2 pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2022.152236_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570993","article-title":"Controlling cytokine storm is vital in COVID-19","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2022.152236_b0150","doi-asserted-by":"crossref","unstructured":"Tang, Y., Sun., J., Pan, H. F., Yao, Y.,Yuan ., Li, Y., 2021.Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity. Cytokine 143, 155523.","DOI":"10.1016\/j.cyto.2021.155523"},{"issue":"9","key":"10.1016\/j.imbio.2022.152236_b0155","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/biomedicines9091228","article-title":"Synergistic effect of static compliance and d-dimers to predict outcome of patients with COVID-19-ARDS: a prospective multicenter study","volume":"9","author":"Tonetti","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.imbio.2022.152236_b0160","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.imbio.2022.152236_b0165","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41423-020-00557-9","article-title":"Unique immunological profile in patients with COVID-19","volume":"18","author":"Varchetta","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.imbio.2022.152236_b0170","unstructured":"World Health Organization.2020. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance 28 January. WHO 10."},{"key":"10.1016\/j.imbio.2022.152236_b0175","doi-asserted-by":"crossref","unstructured":"Yang, B., Chang, X, J., Huang, W.. Pan, Z. Si., Zhang, C., H. Li., 2021. The role of IL-6\/lymphocyte ratio in the peripheral blood of severe patients with COVID-19. Int .Immunopharmacol. 97, 107569.","DOI":"10.1016\/j.intimp.2021.107569"},{"issue":"1","key":"10.1016\/j.imbio.2022.152236_b0180","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s13054-020-03255-0","article-title":"Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China","volume":"24","author":"Zeng","year":"2020","journal-title":"Crit. Care"},{"issue":"6","key":"10.1016\/j.imbio.2022.152236_b0185","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T- cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl. Sci. Rev."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298522000626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298522000626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:50:05Z","timestamp":1759251005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298522000626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0171298522000626"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152236","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the balance of IL-6\/IL-10 cytokines in severe to critical COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152236"}}